| Nasdaq: DEPO
Depomed, Inc. manufactures and distributes pharmaceutical products. It is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that address large and growing markets and are based on proprietary oral drug delivery technologies. Its products are Gralise and Glumetz. The company was founded on August 7, 1995 by John W. Shell and is headquartered in Menlo Park, CA.